# Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Phase 3 Study)(Study P02692)

> **NCT00751075** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 981 (actual)

## Conditions studied

- Acute Rhinosinusitis

## Interventions

- **DRUG:** mometasone furoate nasal spray (MFNS)
- **DRUG:** MFNS
- **DRUG:** Amoxicillin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00751075
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12-01
- **Primary completion:** 2004-05-06
- **Final completion:** 2004-06-22
- **Target enrollment:** 981 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00751075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00751075, "Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Phase 3 Study)(Study P02692)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00751075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*